Puma Biotechnology Inc. (PBYI) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Puma Biotechnology Inc.

    NASDAQ: PBYI · Real-Time Price · USD
    5.13
    -0.09 (-1.72%)
    At close: Oct 03, 2025, 3:59 PM

    Puma Biotechnology Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 30.28M 21.59M 2K -29.13M
    Depreciation & Amortization
    		 11.52M 11.52M 8.92M 10.6M
    Stock-Based Compensation
    		 8.24M 10.25M 11.83M 32.63M
    Other Working Capital
    		 -16.86M -7.38M -33.6M 9.23M
    Other Non-Cash Items
    		 -519K 1.51M 7.03M 7.2M
    Deferred Income Tax
    		 -7.08M n/a n/a n/a
    Change in Working Capital
    		 -3.54M -17.85M -43.58M -602K
    Operating Cash Flow
    		 38.92M 27.01M -15.8M 20.7M
    Capital Expenditures
    		 -56K -12.64M -7M n/a
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 -76.23M -23.81M -4.84M -38.07M
    Sales Maturities Of Investments
    		 55.85M 17.33M 18.94M 27.19M
    Other Investing Acitivies
    		 n/a -12.5M -4K -19K
    Investing Cash Flow
    		 -20.44M -19.13M 7.1M -10.9M
    Debt Repayment
    		 -33.33M n/a n/a -1.5M
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -666K n/a -300K -30.4M
    Financial Cash Flow
    		 -33.85M n/a 12.2M -31.9M
    Net Cash Flow
    		 -15.37M 7.88M 3.5M -22.16M
    Free Cash Flow
    		 38.86M 14.37M -22.8M 20.7M

    Add to Watchlist